Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Giantonio

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusionP J O'Dwyer, P B Laub, D DeMaria, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancerM L Veronese, J P Stevenson, W Sun, et al.
Urology|March 1, 1997
Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladderR E Greenberg, R R Bahnson, D Wood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinomaT Ciuleanu, I Bazin, D Lungulescu, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusionP J O'Dwyer, P B Laub, D DeMaria, et al.
European Journal of Cancer (Oxford, England : 1990)|February 14, 2004
Phase I trial of UFT/leucovorin and irinotecan in patients with advanced cancerM L Veronese, J P Stevenson, W Sun, et al.
Urology|March 1, 1997
Initial report on intravesical administration of N-trifluoroacetyladriamycin-14-valerate (AD 32) to patients with refractory superficial transitional cell carcinoma of the urinary bladderR E Greenberg, R R Bahnson, D Wood, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinomaT Ciuleanu, I Bazin, D Lungulescu, et al.
Pageof 2